Compounds and compositions for inhibiting the activity of abl1, abl2 and bcr-abl1
US-2018134695-A1 · May 17, 2018 · US
Marzinzik Andreas was listed as an assignee on 2 patent publications in 2018.
| Metric | Value |
|---|---|
| Company | Marzinzik Andreas |
| Year | 2018 |
| Patents | 2 |
Representative publications for Marzinzik Andreas in 2018.
Most common classification codes for Marzinzik Andreas in 2018.
| CPC | Patents |
|---|---|
| A61K31/4025 | 2 |
| A61K31/4155 | 2 |
| A61K31/427 | 2 |
| A61K31/4439 | 2 |
| A61K31/5377 | 2 |
Navigate to parent entity pages.